New York, NY, United States of America

Patrizia Casaccia

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Icahn School of Medicine at Mount Sinai. Active years: 2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Patrizia Casaccia. Retrieved from https://idiyas.com/inventor/patrizia-casaccia

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Patrizia Casaccia

Introduction

Patrizia Casaccia is a prominent inventor based in New York, NY (US). She has made significant contributions to the field of medicine, particularly in the development of compounds that target critical pathways in disease processes.

Latest Patents

Patrizia holds 1 patent for her work on small molecule transcription modulators of bromodomains. This patent relates to compounds and compositions comprising one or more indole analogs. These innovative compounds are particularly useful for treating diseases associated with NF-kB and p53 activity, such as cancer and inflammatory diseases.

Career Highlights

Patrizia is affiliated with the Icahn School of Medicine at Mount Sinai, where she continues her research and development efforts. Her work is instrumental in advancing therapeutic options for patients suffering from complex diseases.

Collaborations

Throughout her career, Patrizia has collaborated with notable colleagues, including Guillermo Gerona-Navarro and Ming-Ming Zhou. These partnerships enhance the impact of her research and contribute to the scientific community.

Conclusion

Patrizia Casaccia's innovative work in the field of medicine exemplifies the importance of research in developing new treatments for serious health conditions. Her contributions are paving the way for future advancements in therapeutic strategies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…